Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response
Identifieur interne : 003377 ( Istex/Corpus ); précédent : 003376; suivant : 003378Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response
Auteurs : Kostic ; Zorica Marinkovic ; Sasa Filipovic ; Dragana MomcilovicSource :
- Movement Disorders [ 0885-3185 ] ; 1993.
English descriptors
- KwdEn :
Abstract
The basal levels of prolactin (PRL) and their changes after i. v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young‐onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older‐onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age‐matched with older‐onset (control A) and young‐onset (controlB) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older‐onset parkinsonians than in controls. This response was even more blunted in young‐onset patients, being significantly more attenuated than in older‐onset PD patients.
Url:
DOI: 10.1002/mds.870080223
Links to Exploration step
ISTEX:BAB0B375305AD9F0F67463C60D0474B492B83F20Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title><author><name sortKey="Kostic" sort="Kostic" uniqKey="Kostic" last="Kostic">Kostic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author><author><name sortKey="Marinkovic, Zorica" sort="Marinkovic, Zorica" uniqKey="Marinkovic Z" first="Zorica" last="Marinkovic">Zorica Marinkovic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author><author><name sortKey="Filipovic, Sasa" sort="Filipovic, Sasa" uniqKey="Filipovic S" first="Sasa" last="Filipovic">Sasa Filipovic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author><author><name sortKey="Momcilovic, Dragana" sort="Momcilovic, Dragana" uniqKey="Momcilovic D" first="Dragana" last="Momcilovic">Dragana Momcilovic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BAB0B375305AD9F0F67463C60D0474B492B83F20</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1002/mds.870080223</idno><idno type="url">https://api.istex.fr/document/BAB0B375305AD9F0F67463C60D0474B492B83F20/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003377</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title><author><name sortKey="Kostic" sort="Kostic" uniqKey="Kostic" last="Kostic">Kostic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author><author><name sortKey="Marinkovic, Zorica" sort="Marinkovic, Zorica" uniqKey="Marinkovic Z" first="Zorica" last="Marinkovic">Zorica Marinkovic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author><author><name sortKey="Filipovic, Sasa" sort="Filipovic, Sasa" uniqKey="Filipovic S" first="Sasa" last="Filipovic">Sasa Filipovic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author><author><name sortKey="Momcilovic, Dragana" sort="Momcilovic, Dragana" uniqKey="Momcilovic D" first="Dragana" last="Momcilovic">Dragana Momcilovic</name><affiliation><mods:affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1993">1993</date><biblScope unit="vol">8</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="227">227</biblScope><biblScope unit="page" to="229">229</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">BAB0B375305AD9F0F67463C60D0474B492B83F20</idno><idno type="DOI">10.1002/mds.870080223</idno><idno type="ArticleID">MDS870080223</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Prolactin</term><term>Young‐onset Parkinson's disease</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The basal levels of prolactin (PRL) and their changes after i. v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young‐onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older‐onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age‐matched with older‐onset (control A) and young‐onset (controlB) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older‐onset parkinsonians than in controls. This response was even more blunted in young‐onset patients, being significantly more attenuated than in older‐onset PD patients.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. Kostic</name><affiliations><json:string>Department of Neurology, School of Medicine, Belgrade, Serbia</json:string></affiliations></json:item><json:item><name>Zorica Marinkovic</name><affiliations><json:string>Department of Neurology, School of Medicine, Belgrade, Serbia</json:string></affiliations></json:item><json:item><name>Sasa Filipovic</name><affiliations><json:string>Department of Neurology, School of Medicine, Belgrade, Serbia</json:string></affiliations></json:item><json:item><name>Dragana Momcilovic</name><affiliations><json:string>Department of Neurology, School of Medicine, Belgrade, Serbia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Young‐onset Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Prolactin</value></json:item></subject><language><json:string>eng</json:string></language><abstract>The basal levels of prolactin (PRL) and their changes after i. v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young‐onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older‐onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age‐matched with older‐onset (control A) and young‐onset (controlB) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older‐onset parkinsonians than in controls. This response was even more blunted in young‐onset patients, being significantly more attenuated than in older‐onset PD patients.</abstract><qualityIndicators><score>3.396</score><pdfVersion>1.3</pdfVersion><pdfPageSize>576 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>785</abstractCharCount><pdfWordCount>1992</pdfWordCount><pdfCharCount>12290</pdfCharCount><pdfPageCount>3</pdfPageCount><abstractWordCount>117</abstractWordCount></qualityIndicators><title>Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title><genre><json:string>Serial article</json:string></genre><host><volume>8</volume><pages><total>3</total><last>229</last><first>227</first></pages><issn><json:string>0885-3185</json:string></issn><issue>2</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1993</publicationDate><copyrightDate>1993</copyrightDate><doi><json:string>10.1002/mds.870080223</json:string></doi><id>BAB0B375305AD9F0F67463C60D0474B492B83F20</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/BAB0B375305AD9F0F67463C60D0474B492B83F20/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/BAB0B375305AD9F0F67463C60D0474B492B83F20/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/BAB0B375305AD9F0F67463C60D0474B492B83F20/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1993</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title><author><persName><surname>Kostic</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurology UCC, ul. Dr Subotica 6, 11000 Belgrade, Serbia</p></note><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation></author><author><persName><forename type="first">Zorica</forename><surname>Marinkovic</surname></persName><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation></author><author><persName><forename type="first">Sasa</forename><surname>Filipovic</surname></persName><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation></author><author><persName><forename type="first">Dragana</forename><surname>Momcilovic</surname></persName><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1993"></date><biblScope unit="vol">8</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="227">227</biblScope><biblScope unit="page" to="229">229</biblScope></imprint></monogr><idno type="istex">BAB0B375305AD9F0F67463C60D0474B492B83F20</idno><idno type="DOI">10.1002/mds.870080223</idno><idno type="ArticleID">MDS870080223</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1993</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The basal levels of prolactin (PRL) and their changes after i. v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young‐onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older‐onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age‐matched with older‐onset (control A) and young‐onset (controlB) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older‐onset parkinsonians than in controls. This response was even more blunted in young‐onset patients, being significantly more attenuated than in older‐onset PD patients.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Young‐onset Parkinson's disease</term></item><item><term>Prolactin</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1993">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/BAB0B375305AD9F0F67463C60D0474B492B83F20/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="tocForm">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="20"><doi origin="wiley" registered="yes">10.1002/mds.v8:2</doi><numberingGroup><numbering type="journalVolume" number="8">8</numbering><numbering type="journalIssue">2</numbering></numberingGroup><coverDate startDate="1993">1993</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="23" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870080223</doi><idGroup><id type="unit" value="MDS870080223"></id></idGroup><countGroup><count type="pageTotal" number="3"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 1993 Movement Disorder Society</copyright><eventGroup><event type="firstOnline" date="2004-10-12"></event><event type="publishedOnlineFinalForm" date="2004-10-12"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">227</numbering><numbering type="pageLast">229</numbering></numberingGroup><correspondenceTo>Department of Neurology UCC, ul. Dr Subotica 6, 11000 Belgrade, Serbia</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870080223.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="18"></count></countGroup><titleGroup><title type="main" xml:lang="en">Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title><title type="short" xml:lang="en">YOUNG‐ONSET PD: PROLACTIN RESPONSE</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>Vladimir S.</givenNames><familyName>Kostic</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Zorica</givenNames><familyName>Marinkovic</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Sasa</givenNames><familyName>Filipovic</familyName></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Dragana</givenNames><familyName>Momcilovic</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="GB" type="organization"><unparsedAffiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Young‐onset Parkinson's disease</keyword><keyword xml:id="kwd2">Prolactin</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The basal levels of prolactin (PRL) and their changes after i. v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young‐onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older‐onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age‐matched with older‐onset (control A) and young‐onset (controlB) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older‐onset parkinsonians than in controls. This response was even more blunted in young‐onset patients, being significantly more attenuated than in older‐onset PD patients.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>YOUNG‐ONSET PD: PROLACTIN RESPONSE</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Kostic</namePart><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation><description>Correspondence: Department of Neurology UCC, ul. Dr Subotica 6, 11000 Belgrade, Serbia</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Zorica</namePart><namePart type="family">Marinkovic</namePart><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sasa</namePart><namePart type="family">Filipovic</namePart><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Dragana</namePart><namePart type="family">Momcilovic</namePart><affiliation>Department of Neurology, School of Medicine, Belgrade, Serbia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1993</dateIssued><copyrightDate encoding="w3cdtf">1993</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="tables">2</extent><extent unit="references">18</extent></physicalDescription><abstract lang="en">The basal levels of prolactin (PRL) and their changes after i. v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young‐onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older‐onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age‐matched with older‐onset (control A) and young‐onset (controlB) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older‐onset parkinsonians than in controls. This response was even more blunted in young‐onset patients, being significantly more attenuated than in older‐onset PD patients.</abstract><subject lang="en"><genre>Keywords</genre><topic>Young‐onset Parkinson's disease</topic><topic>Prolactin</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>227</start><end>229</end><total>3</total></extent></part></relatedItem><identifier type="istex">BAB0B375305AD9F0F67463C60D0474B492B83F20</identifier><identifier type="DOI">10.1002/mds.870080223</identifier><identifier type="ArticleID">MDS870080223</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1993 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003377 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003377 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:BAB0B375305AD9F0F67463C60D0474B492B83F20
|texte= Function of dopamine receptors in young‐onset parkinson's disease: Prolactin response
}}
| This area was generated with Dilib version V0.6.23. |  |